Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

12 week prospective double blind placebo controlled randomized trial of Seroquel SR for alcohol dependence and comorbid anxiety

Trial Profile

12 week prospective double blind placebo controlled randomized trial of Seroquel SR for alcohol dependence and comorbid anxiety

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2008

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Alcoholism; Anxiety disorders
  • Focus Therapeutic Use

Most Recent Events

  • 30 Nov 2008 Status changed from recruiting to completed.
  • 08 Apr 2008 The expected completion date for this trial is now 1 Jul 2008, as reported by clinicaltrials.gov.
  • 23 Aug 2007 Status changed from initiated to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top